Market Overview - The U.S. markets experienced significant declines, with 75.6% of equities falling, marking one of the most bearish days in recent memory [2] - The Russell 2000 index fell by 2.8%, while the tech-heavy Nasdaq Composite dropped 2.29%, experiencing its worst day since October 10 [1][3] - The S&P 500 and Dow also faced declines of 1.66% and 1.65% respectively, ending a two-day rally [1] Technology Sector - Major technology stocks such as Tesla (-7.8%), Broadcom (-5.5%), and Nvidia (-4.8%) contributed to the overall market downturn [3][12] - The technology and industrial sectors are showing significant weakness, with many stocks in the capital markets also declining due to falling cryptocurrency values [4] Economic Indicators - Investors are uncertain about a potential rate cut at the Federal Reserve's upcoming meeting, with odds currently at 49.4% [5] - The reopening of the government is expected to bring delayed economic data, which could influence the Fed's decisions moving forward [6][23] Company Earnings - Virgin Galactic reported an EPS of -$1.09 and expects its first commercial spaceflight by Q4 2026, with most customers anticipated to fly in 2027 [1] - Disney's stock fell 9% after reporting adjusted earnings of $1.11 on $22.46 billion in revenue, missing revenue expectations of $22.75 billion [19][20] - Notable gainers included Cellebrite DI (+23%) and Ondas Holdings (+22.2%), both reporting strong earnings [7] Layoffs and Corporate Actions - Verizon is set to conduct its largest-ever layoff, cutting 15,000 jobs, which is about 15% of its workforce [18] - Bitdeer Technologies saw a significant drop of 18.9% after announcing a $148.4 million direct offering and a $400 million convertible bond sale, leading to concerns over dilution [9]

Core Insights - TransAct Technologies Incorporated (TACT) reported break-even quarterly earnings per share, surpassing the Zacks Consensus Estimate of a loss of $0.02, and showing improvement from a loss of $0.06 per share a year ago, resulting in an earnings surprise of +100.00% [1] - The company posted revenues of $13.18 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 0.58% and up from $10.87 million year-over-year [2] - TransAct Technologies has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] Financial Performance - The company has shown a significant earnings surprise of +80% in the previous quarter, where it was expected to post a loss of $0.05 per share but reported a loss of only $0.01 [1] - The current consensus EPS estimate for the upcoming quarter is -$0.09 on revenues of $11.8 million, and for the current fiscal year, it is -$0.15 on revenues of $51.75 million [7] Market Position - TransAct Technologies shares have increased by approximately 5.3% since the beginning of the year, while the S&P 500 has gained 14.4%, indicating underperformance relative to the broader market [3] - The Zacks Industry Rank for Computer - Peripheral Equipment places it in the top 22% of over 250 Zacks industries, suggesting a favorable industry outlook [8] Future Outlook - The sustainability of the stock's price movement will largely depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] - The estimate revisions trend for TransAct Technologies was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6]

Core Insights - Greenhaven Road Capital reported a third-quarter 2025 return of approximately -9%, with year-to-date returns also at -9% due to factors such as lack of investment in AI and insufficient holdings in small, high-growth companies [1] Company Overview - Cellebrite DI Ltd. (NASDAQ:CLBT) is a software company focused on solutions for legally sanctioned investigations, headquartered in Petah Tikva, Israel [2] - The stock of Cellebrite DI Ltd. experienced a one-month return of -21.27% and a 52-week decline of 16.17%, closing at $15.40 per share with a market capitalization of $3.765 billion as of November 7, 2025 [2] Financial Performance - Cellebrite DI Ltd. reported Q2 2025 revenue of $113.3 million, an 18% increase from Q2 2024, driven by a 21% growth in subscription revenue [4] Market Position and Valuation - The Enterprise Value to Next 12 Months Revenue for medium growth companies, which includes Cellebrite, declined from 10.6X at the start of the year to 7.8X by the end of Q3, indicating a 26% decrease in valuation metrics for medium growth software companies [3] - Cellebrite DI Ltd. was held by 38 hedge fund portfolios at the end of Q2 2025, an increase from 30 in the previous quarter, but it is not among the 30 most popular stocks among hedge funds [4]

Core Insights - The fund experienced a return of approximately -9% during Q3, leading to a year-to-date return of approximately -9% [2] - The portfolio lacks direct exposure to AI, focusing instead on companies that are integrating AI into their operations, which has affected short-term performance [3][5] - The investment strategy emphasizes long-term growth potential and durable competitive advantages rather than short-term market trends [5][8] Portfolio Analysis - The top five holdings include PAR Technologies, Cellebrite, KKR, LifeCore, and Burford, all of which have faced declines in share price year-to-date [7][32] - LifeCore's share price dropped over 10% following a shelf offering announcement, despite positive business developments [12][15] - Cellebrite's valuation has been impacted by a general decline in software multiples, with a 26% drop in Enterprise Value to Next 12 Months Revenue for medium growth companies [17][18] Company-Specific Developments - LifeCore is expected to ramp up revenues significantly by 2026, driven by new customer wins and favorable regulatory changes [13][15] - Cellebrite is positioned to benefit from AI advancements, with plans to release investigative AI tools in January 2026 [20][22] - KKR's diversified asset management approach remains robust, with significant growth in Fee Related Earnings and a focus on expanding its investor base [25][31] Market Trends and Challenges - The current market environment has led to a compression of software multiples, affecting companies like Cellebrite and PAR Technologies [18][46] - Concerns regarding traditional private equity and private credit have emerged, but KKR's diversified model mitigates some of these risks [24][30] - The investment landscape is characterized by volatility, with a disconnect between share prices and underlying business progress [10][42] Future Outlook - The fund's strategy focuses on long-term value realization, with expectations that current market conditions will eventually improve for the companies held [9][43] - There is potential for significant growth in companies like Hagerty and Kingsway, driven by strategic partnerships and management quality [33][35] - The outlook for PAR Technologies hinges on winning key contracts, which could substantially increase recurring revenue and growth rates [51][60]

Core Insights - Five9 reported quarterly earnings of $0.78 per share, exceeding the Zacks Consensus Estimate of $0.73 per share, and showing an increase from $0.67 per share a year ago, resulting in an earnings surprise of +6.85% [1] - The company achieved revenues of $285.83 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.46% and up from $264.18 million year-over-year [2] Financial Performance - Five9 has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] - The company has also topped consensus revenue estimates four times in the last four quarters [2] Stock Performance and Outlook - Five9 shares have declined approximately 44% since the beginning of the year, contrasting with the S&P 500's gain of 15.6% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] Earnings Estimate Revisions - The trend for earnings estimate revisions for Five9 was favorable ahead of the earnings release, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] - Current consensus EPS estimate for the next quarter is $0.78 on revenues of $299.98 million, and for the current fiscal year, it is $2.88 on revenues of $1.15 billion [7] Industry Context - The Internet - Software industry, to which Five9 belongs, is currently ranked in the top 35% of over 250 Zacks industries, suggesting a favorable environment for stock performance [8]

Unity Software Inc. (U) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to a loss of $0.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +17.65%. A quarter ago, it was expected that this company would post a loss of $0.25 per share when it actually produced a loss of $0.26, delivering a surprise of -4%.Over the last four quarters, the company has surp ...

分组1 - Dayforce reported quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.56 per share, and down from $0.47 per share a year ago, representing an earnings surprise of -33.93% [1] - The company posted revenues of $481.6 million for the quarter ended September 2025, in line with the Zacks Consensus Estimate, and up from $440 million year-over-year [2] - Dayforce has surpassed consensus revenue estimates four times over the last four quarters [2] 分组2 - The stock has underperformed, losing about 5.8% since the beginning of the year compared to the S&P 500's gain of 17.2% [3] - The current consensus EPS estimate for the coming quarter is $0.69 on revenues of $518.49 million, and for the current fiscal year, it is $2.44 on revenues of $1.95 billion [7] - The Zacks Industry Rank for Internet - Software is currently in the top 30% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]

Core Thesis - Cellebrite DI Ltd. is a high-quality software company dominating digital investigations with a strong public-sector presence and significant growth potential [2][4] Financial Performance - As of October 9th, Cellebrite's share price was $19.05, with a trailing P/E ratio of 10.08 [1] - The company is valued at $4.6 billion, experiencing over 20% year-over-year revenue growth, 85% gross margins, and 26% free cash flow margins, with no debt [2] Product Offering - The core Digital Forensics Suite accounts for 80% of revenue and is essential for global investigations, while cloud-based products like Guardian and Pathfinder are doubling in revenue annually [3] Market Position and Growth Drivers - Despite a strong market position, only 5-8% of potential users currently have licenses, indicating significant room for growth as agencies seek to reduce backlogs [4] - Anticipated FedRAMP authorization by Q3 2025 is expected to unlock nationwide cloud adoption, potentially adding over $150 million in annual recurring revenue [4] Strategic Opportunities - There is potential for a sale to strategic or private equity buyers, supported by activist pressure and a significant stake held by SunCorp [5] - Under conservative assumptions, intrinsic value suggests approximately 100% upside over three years, with upcoming catalysts like FedRAMP approval and public safety funding for the 2026 World Cup [5] Market Sentiment - Shares have corrected approximately 30% due to transient fears over budget delays and management turnover, creating a disconnect from the company's fundamentals [3]

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The third quarter continued the market rally in May and June following waning policy uncertainty, a Fed rate cut, and animal spirits fueled by retail enthusiasm for high-growth potential markets, resulting in another double-digit gain. However, the strategy underperformed the benchmark, the Russell 2000 Growth Index, ...

Market Overview - The Russell 2000 Growth Index closed the third quarter up 12.2%, outperforming the Russell 1000 Growth Index which returned 10.5% [2] - Performance was driven by low-quality stocks, with the lowest-return on equity quintile up 22%, non-earners up 23%, and stocks with no sales up 19% [3] Macroeconomic Factors - The passage of the reconciliation bill and various trade deals reduced market uncertainty, contributing to solid consumer spending and business activity [4] - The Federal Reserve initiated a rate-cutting cycle, starting with a 25 basis point cut in September, which is expected to support market stability and M&A activity [5] Portfolio Performance - The ClearBridge Small Cap Growth Strategy underperformed its benchmark, with gains in industrials and health care sectors but weakness in IT and consumer discretionary sectors [6][16] - Weak traffic data in the consumer discretionary sector impacted holdings like Shift4 Payments, Dutch Bros, and Wingstop, although these companies are viewed as having strong future growth potential [7] Sector Highlights - The industrials sector showed positive performance, particularly in aerospace and defense holdings, while health care also performed well, especially in biotech [9][10] - The IT sector experienced divergent performance, with concerns around AI disintermediation affecting many software stocks [8] New Investments - Seven new investments were added during the quarter, including Karman Holdings and Kratos Defense & Security Systems, which are positioned for significant growth in defense and aerospace [12][21] - Exited positions included Blueprint Medicines and Integral Ad Science due to acquisitions and other fundamental considerations [12] Outlook - The company remains focused on identifying strong growth opportunities despite macroeconomic uncertainties, emphasizing a balanced approach to risk and opportunity [13][15] - The improved stability in government policy and trade dynamics is expected to support broader market participation and investment in higher-quality businesses [14]